109 related articles for article (PubMed ID: 17611353)
1. Expression patterns of the BRCA1 splicing variants in canine normal tissues and mammary gland tumors.
Sugiura T; Matsuyama S; Akiyosi H; Takenaka S; Yamate J; Kuwamura M; Aoki M; Shimada T; Ohashi F; Kubo K
J Vet Med Sci; 2007 Jun; 69(6):587-92. PubMed ID: 17611353
[TBL] [Abstract][Full Text] [Related]
2. Promoter mutation and reduced expression of BRCA1 in canine mammary tumors.
Qiu HB; Sun WD; Yang X; Jiang QY; Chen S; Lin DG
Res Vet Sci; 2015 Dec; 103():143-8. PubMed ID: 26679809
[TBL] [Abstract][Full Text] [Related]
3. Reduced canine BRCA2 expression levels in mammary gland tumors.
Yoshikawa Y; Morimatsu M; Ochiai K; Ishiguro-Oonuma T; Wada S; Orino K; Watanabe K
BMC Vet Res; 2015 Jul; 11():159. PubMed ID: 26202431
[TBL] [Abstract][Full Text] [Related]
4. Expression patterns of the erbB subfamily mRNA in canine benign and malignant mammary tumors.
Matsuyama S; Nakamura M; Yonezawa K; Shimada T; Ohashi F; Takamori Y; Kubo K
J Vet Med Sci; 2001 Sep; 63(9):949-54. PubMed ID: 11642281
[TBL] [Abstract][Full Text] [Related]
5. The canine kallikrein-related peptidase 14: structural characterization, alternative splicing and differential expression in mammary cancer.
Angelopoulou K; Prassas I; Yousef GM
Gene; 2009 Oct; 446(2):68-74. PubMed ID: 19619623
[TBL] [Abstract][Full Text] [Related]
6. Roles of DNA mutation in the coding region and DNA methylation in the 5' flanking region of BRCA1 in canine mammary tumors.
Qiu H; Lin D
J Vet Med Sci; 2016 Jul; 78(6):943-9. PubMed ID: 26888582
[TBL] [Abstract][Full Text] [Related]
7. Expression patterns of the slit subfamily mRNA in canine malignant mammary tumors.
Tanno T; Tanaka Y; Sugiura T; Akiyoshi H; Takenaka S; Kuwamura M; Yamate J; Ohashi F; Kubo K; Tsuyama S
J Vet Med Sci; 2006 Nov; 68(11):1173-7. PubMed ID: 17146174
[TBL] [Abstract][Full Text] [Related]
8. Frequent expression of the c-kit proto-oncogene in canine malignant mammary tumor.
Kubo K; Matsuyama S; Katayama K; Tsutsumi C; Yonezawa K; Shimada T; Kotani T; Sakuma S; Ohashi F; Takamori Y
J Vet Med Sci; 1998 Dec; 60(12):1335-40. PubMed ID: 9879535
[TBL] [Abstract][Full Text] [Related]
9. Expression of the oncogene c-erbB-2 in canine mammary cancers and tumor-derived cell lines.
Ahern TE; Bird RC; Bird AE; Wolfe LG
Am J Vet Res; 1996 May; 57(5):693-6. PubMed ID: 8723884
[TBL] [Abstract][Full Text] [Related]
10. Expression patterns of connexin 26 and connexin 43 mRNA in canine benign and malignant mammary tumours.
Gotoh H; Harada K; Suzuki K; Hashimoto S; Yamamura H; Sato T; Fukumoto K; Hagiwara H; Ishida T; Yamada K; Asano R; Yano T
Vet J; 2006 Jul; 172(1):178-80. PubMed ID: 16772144
[TBL] [Abstract][Full Text] [Related]
11. Derlin-1 and stanniocalcin-1 are differentially regulated in metastasizing canine mammary adenocarcinomas.
Klopfleisch R; Gruber AD
J Comp Pathol; 2009; 141(2-3):113-20. PubMed ID: 19515379
[TBL] [Abstract][Full Text] [Related]
12. Increased expression of BRCA2 and RAD51 in lymph node metastases of canine mammary adenocarcinomas.
Klopfleisch R; Gruber AD
Vet Pathol; 2009 May; 46(3):416-22. PubMed ID: 19176491
[TBL] [Abstract][Full Text] [Related]
13. Breed-related differences in altered BRCA1 expression, phenotype and subtype in malignant canine mammary tumors.
Im KS; Kim IH; Kim NH; Lim HY; Kim JH; Sur JH
Vet J; 2013 Mar; 195(3):366-72. PubMed ID: 22901454
[TBL] [Abstract][Full Text] [Related]
14. Telomerase reverse transcriptase (TERT) expression in canine mammary tissues: a specific marker for malignancy?
Zavlaris M; Angelopoulou K; Vlemmas I; Papaioannou N
Anticancer Res; 2009 Jan; 29(1):319-25. PubMed ID: 19331168
[TBL] [Abstract][Full Text] [Related]
15. Relationship between three novel SNPs of BRCA1 and canine mammary tumors.
Sun W; Yang X; Qiu H; Zhang D; Wang H; Huang J; Lin D
J Vet Med Sci; 2015 Nov; 77(11):1541-3. PubMed ID: 26156012
[TBL] [Abstract][Full Text] [Related]
16. Genetic variations of BRCA1 and BRCA2 genes in dogs with mammary tumours.
Enginler SO; Akış I; Toydemir TS; Oztabak K; Haktanir D; Gündüz MC; Kırşan I; Fırat I
Vet Res Commun; 2014 Mar; 38(1):21-7. PubMed ID: 24122022
[TBL] [Abstract][Full Text] [Related]
17. Expression of Brca1 and splice variant Brca1delta11 RNA levels in mouse mammary gland during normal development and tumorigenesis.
Mixon M; Kittrell F; Medina D
Oncogene; 2000 Nov; 19(46):5237-43. PubMed ID: 11077440
[TBL] [Abstract][Full Text] [Related]
18. Structural characterization and expression of five novel canine kallikrein-related peptidases in mammary cancer.
Angelopoulou K; Karagiannis GS
Mamm Genome; 2010 Oct; 21(9-10):516-24. PubMed ID: 20853168
[TBL] [Abstract][Full Text] [Related]
19. Research progress of good markers for canine mammary carcinoma.
Yang NY; Zheng HH; Yu C; Ye Y; Du CT; Xie GH
Mol Biol Rep; 2023 Dec; 50(12):10617-10625. PubMed ID: 37943402
[TBL] [Abstract][Full Text] [Related]
20. Lymphocyte infiltration, expression of interleukin (IL) -1, IL-6 and expression of mutated breast cancer susceptibility gene-1 correlate with malignancy of canine mammary tumours.
Kim JH; Yu CH; Yhee JY; Im KS; Sur JH
J Comp Pathol; 2010; 142(2-3):177-86. PubMed ID: 19959182
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
